comparemela.com

Latest Breaking News On - Respirerx pharmaceuticals inc - Page 4 : comparemela.com

RespireRx Transferes Its Pharmaceutical Cannabinoid Program To ResolutionRx - RespireRx Pharma (OTC:RSPI)

RespireRx Pharmaceuticals Inc. (OTCPK:RSPI), focused on the discovery and development of treatments to combat diseases caused by disruption of neuronal signaling, and ResolutionRx Ltd, an unlisted public Australian company, and a subsidiary of RespireRx on August 3, 2023, entered into a series of bilateral agreements intended to transfer the Re

Comparing RespireRx Pharmaceuticals (RSPI) & Its Rivals

RespireRx Pharmaceuticals (OTCMKTS:RSPI – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare RespireRx Pharmaceuticals to similar companies based on the strength of its profitability, dividends, risk, institutional ownership, earnings, valuation and analyst recommendations. Analyst Recommendations This […]

Analyzing RespireRx Pharmaceuticals (RSPI) and The Competition

RespireRx Pharmaceuticals (OTCMKTS:RSPI – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare RespireRx Pharmaceuticals to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Volatility and Risk […]

RespireRx Pharmaceuticals Inc (OTCMKTS:RSPI) Short Interest Up 127 4% in June

RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Free Report) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 14,100 shares, a growth of 127.4% from the May 31st total of 6,200 shares. Based on an average daily volume of 7,718,200 shares, the days-to-cover ratio is […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.